Denali Therapeutics Conference Call Summary Company Overview - **Company**: Denali Therapeutics (NasdaqGS:DNLI) - **Product**: AVLAYAH (tividenofusp alfa-eknm) - **Indication**: Treatment of Hunter syndrome (MPS II) Key Points FDA Approval and Product Significance - Denali announced the FDA approval of AVLAYAH, the first enzyme replacement therapy designed to cross the blood-brain barrier for Hunter syndrome [2][3] - This approval is a historic milestone, marking the first meaningful therapeutic advance for the MPS II community in nearly two decades [7] - AVLAYAH is designed to address both systemic and neurological manifestations of Hunter syndrome, a progressive, life-limiting condition affecting children [6][12] Clinical Data and Efficacy - AVLAYAH demonstrated a significant 91% mean reduction in cerebrospinal fluid (CSF) heparan sulfate levels from baseline, with 93% of patients achieving levels below the upper limit of normal at week 24 [18] - The treatment also normalized urine GAG levels in 68% of patients by week 24, indicating effective clearance of peripheral substrate [18] - Clinical data published in the New England Journal of Medicine showed large and sustained reductions in biomarkers of disease activity in both the CNS and periphery [14][15] Commercialization Strategy - Denali is prepared for the commercial launch of AVLAYAH, with a focus on engaging the MPS II community and ensuring patient access [20][24] - The company aims to capture approximately 75% of the treated U.S. prevalent population, which consists of around 500 patients [22] - Denali's pricing strategy includes a wholesale acquisition cost of $5,200 per 150-mg vial, with annual costs for maintenance dosing ranging from approximately $270,000 to $811,000 depending on patient weight [26] Market Dynamics and Patient Engagement - The MPS II market is characterized by a concentrated prescriber base, with most patients managed by clinical geneticists in about 100 centers of excellence [24] - Denali has established relationships with major MPS II centers and has a sales team with extensive experience in rare diseases [25] - The company has engaged with payers covering approximately 90% of commercial lives, receiving constructive feedback regarding the unmet need for AVLAYAH [23] Future Outlook and Pipeline Expansion - Denali views AVLAYAH as the foundation for a durable multi-program franchise in lysosomal storage disorders, with plans to expand into other diseases such as Sanfilippo syndrome and Alzheimer's disease [32][34] - The approval of AVLAYAH sets a precedent for using CSF heparan sulfate as a surrogate biomarker for future regulatory submissions [56][97] Safety and Monitoring - Safety data indicated that infusion-related reactions were the most common adverse events, with manageable incidence over time [16] - The prescribing information includes guidance on monitoring for hypersensitivity and anemia, which are common concerns with enzyme replacement therapies [18] Conclusion - Denali Therapeutics is positioned for a successful launch of AVLAYAH, addressing a critical unmet need in the treatment of Hunter syndrome and paving the way for future innovations in rare diseases [27][34]

Summary of NeoVolta Conference Call Company Overview - **Company Name**: NeoVolta - **Founded**: 2018 in Southern California - **Industry**: Energy storage technology Key Points and Arguments - **Leadership Change**: In mid-2024, NeoVolta hired Ardes Johnson as CEO, who has a background from GE and Tesla, to expand the company's geographic and product scope, leading to record fiscal 2025 results [2][3] - **Business Model Adjustment**: In summer 2025, NeoVolta adjusted its business model to expand into commercial and industrial (C&I) markets due to increased competition in the residential space and the passage of the OB bill [3] - **Record Growth**: The last quarter ending December 31, 2025, showed a record growth of 334% year-over-year, with a half-year growth of 580% [3] - **Market Positioning**: NeoVolta aims to differentiate itself from competitors like Tesla by being a pure play storage company, focusing on user-friendly products and expanding into various power generation sources beyond solar [4][7] - **Energy Storage Importance**: The company emphasizes the need for energy storage solutions due to increasing electrification and grid instability, positioning batteries as a key solution for residential, commercial, and utility markets [6][7] Financial Performance - **Revenue Growth**: Fiscal 2024 revenue was $2.6 million, with rapid growth following a strategic shift to a nationwide approach and diversified product offerings [8] - **Market Expansion**: The total addressable market expanded from $15 billion to $45 billion by 2030, with significant potential in utility-scale and C&I markets [10][11] Strategic Partnerships and Acquisitions - **Acquisition of Neubau**: NeoVolta acquired technology and assets from Neubau, a non-Chinese battery energy storage company, to enhance its product offerings and comply with financing regulations [11][12] - **Collaboration with Luminia**: A partnership with Luminia aims to standardize C&I storage delivery and ease grid strain, positioning NeoVolta as a leader in the C&I market [13][14] - **Joint Venture with Powin and Longi**: A joint venture to build a 2 GWh battery energy storage plant in Georgia, primarily for utility-scale output, is expected to generate significant revenue [14][15] Future Outlook - **Revenue Potential**: The joint venture plant has an illustrative annual revenue potential of $400 million, with expectations for commercial production by late July to August [15][16] - **Business Model Transition**: NeoVolta anticipates continued revenue growth despite current margin thinning due to the transition in business model, aiming to leverage opportunities created by the Build Back Better era [18] - **Capital Structure**: The company plans to raise $7 million by January 2026 and $10 million at commissioning for the plant, primarily through debt and equipment financing [19] Additional Insights - **Accelerated Development**: NeoVolta is experiencing rapid development and growth, with plans to expand its operations and partnerships significantly in the coming years [20][21]

TMX Group FY Conference Summary Company Overview - **Company**: TMX Group (OTCPK:TMXX.F) - **Date of Conference**: March 25, 2026 - **Key Speakers**: Luc Fortin (President and CEO), David Arnold (Chief Financial Officer) Key Points Industry and Market Performance - **Capital Formation**: Strong performance in January and February 2026 with significant secondary financings and IPO activity. The pipeline for IPOs remains robust despite some recent geopolitical impacts [7][8] - **Market Volatility**: The derivatives market experienced increased activity due to volatility, with equity volumes returning to pandemic levels. Concerns exist regarding the impact of prolonged geopolitical tensions on investor appetite [9][10] - **Global Insights**: TMX Datalinx and VettaFi are performing well, with VettaFi's assets under index growing. Trayport, the natural gas and energy trading platform, is also exceeding expectations [11] AI and Data Strategy - **AI Opportunities**: TMX views AI as an opportunity rather than a risk, focusing on enhancing productivity and efficiency rather than fearing disruption. Proprietary data remains a key competitive advantage [12][13][20] - **Data Demand**: There is an increasing demand for high-quality raw data, with clients preferring to generate their own insights rather than relying on AI-generated insights [17][18] Tokenization and Market Infrastructure - **Tokenization Potential**: TMX sees opportunities in tokenization, particularly in facilitating payments and reducing friction in post-trade processes. However, concerns exist about liquidity fragmentation with the current state of tokenized assets [21][22][27] - **Regulatory Alignment**: TMX is closely monitoring U.S. developments in tokenization to ensure alignment and avoid market structure discrepancies that could disadvantage Canadian markets [26][28] Growth Strategies and Initiatives - **Alpha X US Platform**: Launched to enter the U.S. equity market, Alpha X US has exceeded initial performance benchmarks and is expected to capture a growing segment of the market focused on quality execution [33][34] - **Post-Trade Modernization**: The modernization of post-trade infrastructure has improved operational efficiency and security, positioning TMX favorably against competitors [42][43] Financial Strategy and M&A Outlook - **Revenue Diversification**: TMX aims for over 50% of revenue to come from outside Canada and for Global Insights to constitute half of total revenue. The focus is on balancing growth across various business segments [50][51] - **M&A Strategy**: TMX does not have a specific M&A strategy but is open to acquisitions that align with its growth objectives. The company is actively exploring opportunities across its business segments [55][57] Final Thoughts - **Market Positioning**: TMX emphasizes its commitment to innovation and community engagement, aiming to leverage growth opportunities in a globalized market while maintaining its core operational strengths [60][61]

Summary of Pan American Silver Conference Call - March 25, 2026 Company Overview - **Company**: Pan American Silver (NYSE: PAAS) - **Focus**: Revised preliminary economic assessment (PEA) for the La Colorada skarn project Key Points Industry and Project Updates - The conference call discussed the revised PEA for the La Colorada skarn project, highlighting significant exploration advancements since the original PEA in early 2024 [2][3] - The exploration program has led to the discovery of multiple high-grade silver zones, adding 52.7 million ounces of silver to inferred mineral resources [3][4] Development Plan - The revised PEA outlines a new development plan for La Colorada, which includes: - Continued production from the existing mine while developing the higher-grade skarn deposit and newly identified silver veins [4][5] - Construction of a decline from the existing mine to access the skarn deposit, with preliminary work expected to begin in 2026 [4][5] - Engineering work for two shafts (production and ventilation) to start in 2026, with completion expected by 2030 [5] - A new processing plant with a capacity of 15,000 tons per day, expected to be operational by 2032, with a total capital investment estimated at $1.9 billion [5][6] Economic Projections - The revised PEA estimates an after-tax net present value (NPV) of approximately $2.6 billion at a 5% discount rate, with an internal rate of return (IRR) of 17% based on long-term metal prices [10] - Under higher metal price scenarios, the NPV could increase to approximately $5.2 billion, and the IRR could rise to 25% [10] - The payback period for the initial investment is estimated at four years under base case prices, improving to three years under higher price scenarios [11] Production Expectations - Average silver production from the expanded La Colorada mine is expected to be 19.1 million ounces annually during the peak five years, declining to 11 million ounces per year for the subsequent ten years [7] - The exploration upside could extend peak production levels due to the discovery of new high-grade veins [7][8] Cost Structure - Silver all-in sustaining costs are projected to average negative $22.67 per ounce over the initial five years, benefiting from significant by-product credits from zinc and lead [12] - Revenue contributions during the initial five years are expected to be approximately 42% from silver, 39% from zinc, and 19% from lead [12] Technical and Operational Considerations - The mining method has shifted from sub-level caving to conventional long-hole open stoping, which is expected to lower technical risks and costs [8][41] - Direct mining costs for the combined skarn and vein resources are estimated at $54.50 per ton, compared to $160-$180 per ton for current operations [41] Exploration and Future Plans - Ongoing exploration efforts are expected to further enhance mineral resource growth, with significant drilling completed but not included in the PEA [13][25] - The company plans to advance towards a pre-feasibility study and continue exploration drilling in both the skarn and vein areas [13][56] Capital Allocation and Funding - The project is expected to be funded through cash flow generated by existing operations, with no immediate need for external financing [6][87] - The company reported strong free cash flow generation, allowing for continued investment in growth projects and shareholder returns [87] Regulatory and Permitting Aspects - The 588 level ramp decline does not require additional permits, but other components of the expansion will need permitting [6][58] - Discussions with regulators are ongoing to determine the permitting requirements for the new processing plant and other infrastructure [58] Conclusion - The La Colorada project is positioned to become one of the largest and lowest-cost silver mines globally, with a strong focus on exploration and development to maximize production and shareholder value [94][95]

MeiraGTx Conference Summary Company Overview - MeiraGTx is a biotechnology company focused on gene therapies, particularly in ophthalmology and other therapeutic areas. The company has three late-stage programs in ophthalmology for inherited retinal diseases, partnered with Johnson & Johnson (J&J) and Lilly, and two additional programs in xerostomia and Parkinson's disease [2][16][40]. Ophthalmology Programs Inherited Retinal Diseases (IRDs) - MeiraGTx has extensive experience in developing gene therapies for IRDs, including programs for X-linked retinitis pigmentosa (XLRP), Leber congenital amaurosis type 4 (LCA4), and Bardet-Biedl syndrome type 10 (BBS10) [7][20][22]. - The company utilizes adeno-associated virus (AAV) for gene delivery, which allows for safe and effective treatment of these diseases due to the localized nature of the eye [8][9]. - The IRD space is characterized by a small number of key opinion leaders (KOLs) who treat a majority of patients, enhancing collaboration and knowledge sharing [10][12]. Specific Programs - **XLRP Program**: This program is partnered with J&J, and the phase III study showed promising results. MeiraGTx is the commercial manufacturer and is awaiting J&J's strategy for patient access [16][18]. - **LCA4 Program**: This ultra-rare condition has seen successful treatment of 11 children, all of whom gained sight. Lilly has licensed this program with an upfront payment of $75 million and additional milestone payments [20][21]. - **BBS10 Program**: This program was initiated through a patient advocacy group and allows for treatment under a specials license in the UK. The company is also exploring additional IRD treatments under similar conditions [22][24]. Manufacturing and Technology - MeiraGTx supports its programs with internal manufacturing capabilities, which enhance cost efficiency and regulatory speed [3][5]. - The company has developed advanced optimization technologies for gene delivery, improving potency and reducing required dosages [3][4]. Non-Ophthalmology Programs Xerostomia - The xerostomia program targets severe long-term dry mouth resulting from radiation therapy, representing a multi-billion-dollar market opportunity. The pivotal phase II study is nearing completion, with plans to file for approval next year [40][41]. Parkinson's Disease - The Parkinson's program is in collaboration with Hologen, with plans for an IND filing later this year. The company is also exploring the use of riboswitch technology for various therapeutic applications, including pain management [42][43]. Key Takeaways - MeiraGTx is well-positioned in the gene therapy space, particularly in ophthalmology, with a strong pipeline and strategic partnerships. - The company's focus on localized gene delivery and internal manufacturing provides a competitive advantage in terms of cost and regulatory efficiency. - The potential for significant market opportunities exists in both ophthalmology and non-ophthalmology programs, with ongoing developments in various therapeutic areas [2][40][41].

Summary of the Investor Day Conference Call Company and Industry Overview - The conference call focused on Sims Lifecycle Services (SLS), a division of Sims, which specializes in circular cloud solutions and electronic waste management. The company has been operational in this sector since 2019, targeting hyperscalers and building relationships with them [3][11]. Key Points and Arguments Growth and Financial Performance - SLS has experienced rapid growth, particularly in the first half of 2026, with expectations for continued growth in the second half [3][4]. - The EBIT contribution from SLS is projected to become a significant part of Sims' overall business, indicating its importance for future growth [4][5]. - The company is transitioning to a new volume metric, focusing on gigabytes of memory sold instead of repurposed units, to better reflect the value of their products [37][38]. Revenue Streams - SLS generates revenue through three main buckets: resale, service fees, and commodity sales. Resale is currently the largest revenue source, driven by high memory prices [20][41]. - The revenue split between clients and SLS is approximately 70/30, with clients receiving the majority of the revenue, which incentivizes SLS to maximize value [21][104]. Market Dynamics - The demand for DDR4 memory is increasing due to a supply constraint, as major manufacturers have ceased production of DDR4 in favor of DDR5, which is more profitable and efficient [26][27]. - The lifespan of data center equipment is compressing, with a shift from a typical five-year end-of-life cycle to an average of three years, particularly for AI-related equipment [24][25]. Competitive Advantage - SLS has established itself as a leader in redeployment services, which is a unique offering that enhances relationships with hyperscalers [99][102]. - The company has invested in automation and technology to improve efficiency and scalability, allowing it to respond quickly to client needs [44][81]. Geographic Expansion - SLS plans to expand its operations into Ireland, anticipating significant growth in gigabytes sold, with projections of 4 million gigabytes in the first year and 15 million by FY 2029 [42][43]. Other Important Insights - The company emphasizes a capital-light strategy, which allows for high returns on investment without significant capital expenditure [6]. - SLS is positioned to benefit from structural non-cyclical growth in the memory market, with a focus on sustainability and reducing electronic waste [44][45]. - The management team highlighted the importance of compliance and service level agreements (SLAs) in maintaining customer satisfaction and operational efficiency [18][19]. This summary encapsulates the key points discussed during the conference call, providing insights into the company's growth trajectory, market dynamics, and strategic initiatives.

IGM Financial FY Conference Summary Company Overview - **Company**: IGM Financial (OTCPK:IGIF.F) - **Date of Conference**: March 25, 2026 - **Key Speaker**: James O'Sullivan, President and CEO Core Points and Arguments 2025 Performance Highlights - **Net Flows**: Generated almost CAD 9 billion in net flows across IG and Mackenzie, indicating strong performance [9] - **Strategic Investments**: - Rockefeller client assets increased by 34% - Wealthsimple client assets surged by 75% - ChinaAMC assets grew by nearly 30% - Northleaf achieved CAD 35 billion in assets, marking its best fundraising year with almost CAD 6 billion [9] - **Earnings Growth**: Record earnings rose by 17%, allowing for a 10% dividend increase, the first in 11 years [10] - **Capital Return**: Over CAD 800 million returned to shareholders through buybacks and dividends, with a target of CAD 1.1 billion for the current year [10] Strategic Continuity - **Leadership Transition**: Damon Murchison will take over as CEO, with a focus on continuity in strategic priorities and capital allocation [13][15] - **Long-term Strategy**: Emphasis on maintaining momentum and executing existing strategies without sharp turns [16] AI and Digital Platforms - **AI Integration**: IGM is committed to investing in AI, similar to its approach with fintech, to enhance advisor capabilities and client services [21][24] - **Emotional Advice**: AI is expected to enhance offerings but will struggle to replicate the emotional support provided by human advisors [28] - **Quantitative Strategies**: AI is enhancing investment offerings, particularly in quant equity, which is becoming more relevant in retail [30][31] Industry Flow Trends - **2025 Flow Drivers**: Improved flows attributed to settled inflation around 2%, lower interest rates, and persistent wage growth [32][33] - **Retirement Readiness**: Canadians are increasingly focused on retirement readiness, influencing their investment choices [34] High Net Worth Segment - **Strategic Shift**: IGM has moved its focus upmarket to high net worth clients, leveraging fintech to provide tailored services [39][42] - **Service Offerings**: Development of a comprehensive suite of services for advisors, including tax insights and philanthropic advice [41] Mackenzie Performance - **Positive Net Flows**: Mackenzie has seen positive net flows for eight to nine months, with a focus on institutional and active ETFs [46] - **Boutique Strategy**: The success of various boutiques within Mackenzie is contributing to overall momentum [48] Strategic Investments Overview - **Long-term Focus**: IGM is satisfied with its current strategic investments and aims for horizontal connectivity among its businesses [50][51] - **ChinaAMC Potential**: Despite less recent attention, ChinaAMC is viewed as a long-term growth opportunity due to structural reforms in China [53] Additional Important Insights - **Market Conditions**: The overall market backdrop is seen as decent, with expectations for continued growth in flows [48] - **Investment Philosophy**: Emphasis on a sum-of-the-parts valuation approach, considering future earnings potential from Wealthsimple and Rockefeller [54] This summary encapsulates the key points discussed during the IGM Financial FY Conference, highlighting the company's strong performance, strategic direction, and focus on innovation through AI and fintech.

Summary of Intact Financial FY Conference Call (March 25, 2026) Company Overview - **Company**: Intact Financial (OTCPK:IFCZ.F) - **Industry**: Insurance Key Points Financial Performance - **2025 Highlights**: Achieved nearly 20% Return on Equity (ROE) [3] - **Q1 2026 Outlook**: Strong fundamentals with continued top-line growth expected [3][4] - **Combined Ratio**: Maintained a combined ratio below 95, outperforming the industry by 8 points [4] Market Conditions - **Canada**: - Personal lines experiencing hard market conditions with industry running in the 100 zone [4] - Inflation in personal lines is about 5 points, necessitating further rate increases [4] - **U.S.**: - Focused on specialty lines, expecting mid-single-digit growth in 2026 [5] - Growth momentum observed in new business submissions [5][35] - **U.K.**: - Near completion of remediation work on the portfolio acquired from Direct Line [8] AI and Technology Investments - **AI Implementation**: Over 600 AI models deployed, generating CAD 200 million in annual benefits, with a goal of reaching CAD 500 million by 2030 [12][18] - **Focus Areas**: - Improving loss ratios, enhancing customer journeys, and increasing software engineering efficiency [12][13] - **Competitive Advantage**: Scale and proprietary data provide a significant edge in leveraging AI tools [18] ROE Drivers - **Structural vs. Cyclical**: ROE expected to remain in the upper teens, driven by: - Improved business mix towards commercial and specialty lines [25][26] - Effective claims management and internalization of claims processes [24][25] - Strategic capital management [25] - **AI Impact**: AI models are being deployed in commercial lines, contributing to improved combined ratios [31] Operating Environment - **Market Conditions**: - Sustained hard market conditions in personal lines in Canada [34] - Constructive marketplace in commercial lines, with rates sufficient to cover inflation [34] - **Competition**: Increased competition in larger risks, but margins are protected through effective pricing strategies [34] M&A Strategy - **Active Environment**: M&A activity is more robust than in the past 12-18 months [37] - **Criteria for M&A**: Focus on strategic fit, expected minimum 15% return, and overlap with existing operations [37][38] - **Acquisition Capacity**: Potential to deploy around CAD 5 billion in acquisitions without issuing shares, expected to increase to CAD 7 billion by year-end [44] Risks and Opportunities - **Potential Threats**: Competition is a constant concern, but no specific area of vulnerability identified [50] - **Growth Opportunities**: Continued deployment of AI models in new markets and lines of business [51] Investor Insights - **Underappreciated Aspects**: - ROE moving into a new zone and consistent growth in Net Operating Income Per Share (NOIPS) [53] - Favorable development in prior years should be normalized [54] - **Resilience**: Ability to maintain good ROE even in lower profitability cycles [55] This summary encapsulates the key insights from the Intact Financial FY Conference Call, highlighting the company's strong performance, strategic focus on AI, and proactive approach to market conditions and M&A opportunities.

Summary of Cerrado Gold Conference Call (March 25, 2026) Company Overview - **Cerrado Gold** is a junior mining company with a producing gold asset in Argentina, **Minera Don Nicolás**, expected to produce **50,000-60,000 ounces** of gold in 2026 [1][3] - The company is also advancing two other projects: **Lagoa Salgada** in Portugal (polymetallic) and **Mont Sorcier Iron Ore Project** in Quebec, Canada [1][2] Key Points and Arguments Minera Don Nicolás - Production is ramping up from **42,000 ounces** in 2021 to an expected **55,000 ounces** in 2026, with potential increases to **70,000-100,000 ounces** in the coming years [7][12] - A **50,000-meter exploration program** is underway to extend the mine life, which is currently projected to be just under **3 years** [3][11] - The company is targeting higher-grade underground deposits, with **30,000 ounces** identified, and plans to start drilling in June [4][21] Lagoa Salgada Project - Expected to make a construction decision in **Q3 2026**, with production anticipated by **mid-2028** [4][12] - The project has a projected **NPV of CAD 146 million** and is expected to generate **CAD 75 million** in free cash flow based on previous feasibility studies [8][12] - The project includes **40% gold and silver**, **27% zinc**, **15% copper**, and **7% tin**, with bottom quartile costs of **$0.59 per zinc equivalent pound** for the first five years [24][25] Mont Sorcier Iron Ore Project - High-grade iron ore project with **67% purity**, expected to produce **8 million tons** annually by **2030** [5][34] - Previous PEA indicated an **NPV of CAD 1.6 billion** and projected free cash flow of **CAD 235 million** per year, with expectations of increasing to **CAD 400-500 million** [5][34] - The project benefits from existing infrastructure, including rail access to the **Port of Saguenay** [30][31] Financial Highlights - The company expects a cash balance of over **$20 million** by year-end, with potential increases to **$60-90 million** depending on gold prices [6][8] - Projected free cash flow from Argentina alone could exceed **$60 million** annually at current gold prices [8][9] - The company is well-funded and does not anticipate the need for equity financing to advance its projects [36] Market Position and Growth Potential - The company aims to grow cash flow without diluting shareholders, with a target of over **CAD 500 million** in cash flow by **2030** [37] - Current share price around **$1.56** suggests significant room for growth, with target prices from analysts at **CAD 2.50** to **CAD 3.30** [9][37] - The company is positioned to capitalize on the increasing demand for critical minerals in Europe, particularly through the Lagoa Salgada project [8][24] Additional Insights - The company has invested over **CAD 40 million** in its properties and is beginning to see returns on these investments [10][11] - The exploration strategy is focused on expanding resources and mine life, with a significant land package of **330,000 hectares** in Argentina [20][22] - The company is committed to sustainable practices and aims to support the green steel transition through its high-grade iron ore project [5][30] This summary encapsulates the key points discussed during the conference call, highlighting the company's strategic direction, project developments, financial outlook, and market positioning.

Comstock Holding Companies Conference Summary Company Overview - **Company Name**: Comstock Holding Companies (NasdaqCM:CHCI) - **Industry**: Real Estate Development and Services - **Focus**: Mixed-use and transit-oriented properties in the Washington, D.C. region - **Established**: 1985 - **Current Development**: Reston Station, a significant transit-oriented development covering 90 acres with approximately 10 million sq ft planned [1][4] Core Business Model - **Debt-Free Structure**: Comstock operates without debt, which allows for predictable recurring revenue through long-term asset management agreements [2][11] - **Revenue Generation**: The company earns fees through: - Asset management agreements - Property management via subsidiaries (CHCI Commercial, CHCI Residential, ParkX Management) - Supplemental fees from transactions [6][9][10] - **Growth Strategy**: Focus on expanding the managed portfolio and development pipeline, aiming for approximately 20 million sq ft valued at $5 billion-$6 billion in the next 5-7 years [25] Financial Performance - **2025 Financial Results**: - Revenue: $63 million, up 23% - Net Income: $17 million, up 17% - Adjusted EBITDA: $13 million, up 16% - Assets Under Management: 92 assets, up 28% year-over-year [22] - **Revenue Mix**: - 44% from asset management - 23% from ParkX - 19% from property management - 14% from supplemental fees [22] - **Growth Metrics**: Revenue grew at a 23% CAGR and adjusted EBITDA at 31% CAGR from 2020 to 2025, despite market volatility [18] Market Position and Valuation - **Valuation Comparison**: Comstock trades at 6.4x adjusted EBITDA, significantly lower than peers averaging 14.2x [20] - **Stock Performance**: Since 2020, the stock has increased by 493%, while peers have generally declined [21] - **Return on Equity**: 24%, compared to negative returns for peers [21] Strategic Initiatives - **Institutional Venture Platform**: Designed to pair operational expertise with institutional capital for joint ventures, focusing on low-risk, high-value opportunities [24][26] - **Data Center Platform**: A new initiative targeting the growing demand for data center capacity, leveraging existing development expertise [29][31] Operational Highlights - **Managed Portfolio**: As of December 31, 2025, the company managed 92 operating assets, with plans to grow to 105 at full build-out [34] - **Leasing Activity**: Stabilized commercial portfolio is 93% leased, with significant leasing activity in Q4 [23] Conclusion - **Future Outlook**: Comstock is positioned for continued growth with a strong pipeline and a focus on scalable, fee-based operations. The company aims to close the valuation gap with peers while maintaining a debt-free balance sheet [42][43]